VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

Oncotarget
Marlous ArjaansElisabeth G E de Vries

Abstract

Vascular endothelial growth factor (VEGF) pathway targeting agents have been combined with other anticancer drugs, leading to improved efficacy in carcinoma of the cervix, stomach, lung, colon and rectum, ovary, and breast. Vessel normalization induced by VEGF pathway targeting agents influences tumor drug uptake. Following bevacizumab treatment, preclinical and clinical studies have shown a decrease in tumor delivery of radiolabeled antibodies and two chemotherapeutic drugs. The decrease in vessel pore size during vessel normalization might explain the decrease in tumor drug uptake. Moreover, the addition of bevacizumab to cetuximab, or panitumumab in colorectal cancer patients or to trastuzumab in breast cancer patients, did not improve efficacy. However, combining bevacizumab with chemotherapy did increase efficacy in some cancer types. Novel biomarkers to select patients who may benefit from combination therapies, such as the effect of an angiogenesis inhibitor on tumor perfusion, requires innovative trial designs and large clinical trials. Small imaging studies with radiolabeled drugs could be used in the interphase to gain further insight into the interplay between VEGF targeted therapy, vessel normalization and tumor dru...Continue Reading

References

May 20, 1999·The New England Journal of Medicine·R D Rosenberg, W C Aird
Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Jan 30, 2004·Cancer Cell·Mikhail V Blagosklonny
Mar 26, 2004·Angiogenesis·Ugur Ozerdem, William B Stallcup
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 21, 2005·Nature Reviews. Cancer·John J Kim, Ian F Tannock
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G WillettGregory Y Lauwers
Apr 6, 2006·Cancer Research·Edward A Sausville, Angelika M Burger
Jul 17, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Wouter B NagengastMarjolijn N Lub-de Hooge
May 9, 2008·The New England Journal of Medicine·Robert S Kerbel
Jul 1, 2008·The Oncologist·Adrianus J de LangenMark Lubberink
Dec 3, 2008·Disease Models & Mechanisms·Ann Richmond, Yingjun Su
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Randolph HechtRafael G Amado
Feb 7, 2009·The New England Journal of Medicine·Jolien TolCornelis J A Punt
Feb 26, 2009·British Journal of Cancer·J A NagyH F Dvorak
May 16, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Eli C F DijkersMarjolijn N Lub-de Hooge
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G WillettRakesh K Jain
Jul 4, 2009·Experimental and Molecular Pathology·Joel A LeffertsGregory J Tsongalis
Jan 16, 2010·Journal of the National Cancer Institute·Boris FreidlinEdward L Korn
Mar 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio ScagliottiNasser Hanna
May 22, 2010·Seminars in Thrombosis and Hemostasis·Janice A NagyHarold F Dvorak
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Niall C TebbuttTimothy J Price
Aug 24, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Cécile OrtholanGilles Pagès
Oct 5, 2010·Angewandte Chemie·Zoran PopovićMoungi G Bawendi
Oct 20, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Astrid A M van der VeldtMark Lubberink
Nov 9, 2010·Bioconjugate Chemistry·C Andrew BoswellLeslie A Khawli
Jan 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katerina Politi, William Pao
Feb 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard H de BoerJohan F Vansteenkiste
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemEdward Lin
Jun 2, 2011·Nature Reviews. Drug Discovery·Peter Carmeliet, Rakesh K Jain
Jul 12, 2011·Physiological Reviews·Shom GoelRakesh K Jain
Feb 15, 2012·Nature Reviews. Clinical Oncology·Gordon C JaysonLee M Ellis
Feb 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonas BerghCarla Giorgetti

❮ Previous
Next ❯

Citations

Jul 9, 2016·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Daniela PierscianekYuan Zhu
Nov 4, 2017·Future Oncology·Kathleen N MooreMichael J Birrer
Apr 14, 2017·RMD Open·Nicola GoodfellowRaashid Luqmani
Jan 18, 2018·Expert Review of Anticancer Therapy·Francesca BattaglinFotios Loupakis
Dec 21, 2018·Anti-cancer Agents in Medicinal Chemistry·Marina G MoschettaDebora A P de Campos Zuccari
Jan 14, 2017·Expert Opinion on Therapeutic Targets·Anna Rita CantelmoPeter Carmeliet
Jun 24, 2017·Medicinal Research Reviews·Roberto RoncaSandra Liekens
Sep 13, 2019·BMC Public Health·Sávio Lima SodréJose Paulo Cabral de Vasconcellos
Sep 28, 2016·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Vasileios S SkourasKonstantinos N Syrigos
Jan 1, 2016·NPJ Systems Biology and Applications·Jennifer A RohrsStacey D Finley
Sep 13, 2017·Breast Cancer Research : BCR·Imke H BartelinkLaura van 't Veer
Jul 10, 2019·Integrative Cancer Therapies·Jie Zheng, Peng Gao
Apr 30, 2017·Oncology Letters·Carlos Martínez-CampaSamuel Cos
Dec 11, 2019·International Journal of Molecular Sciences·Alessia BrossaBenedetta Bussolati
Aug 10, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Thomas MuellerHans-Joachim Schmoll
Feb 14, 2020·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Zhenjie HuangGuangnan Liu
Oct 3, 2018·Nature Reviews. Endocrinology·Frank J GonzalezChangtao Jiang
Jan 5, 2020·International Journal of Clinical Oncology·Kenji ChamotoTasuku Honjo
Nov 27, 2016·Journal of Experimental & Clinical Cancer Research : CR·Wang LiuXiongwen Zhang
May 26, 2017·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Matteo DonadonGuido Torzilli
Oct 31, 2020·Frontiers in Oncology·Donald M Lamkin, Theodore Garland
Jun 13, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Razelle KurzrockNilofer S Azad
Jul 25, 2021·International Journal of Molecular Sciences·Guido GiordanoMatteo Landriscina

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.